Global Digital Signature Market to Reach $2,934.6 Million by 2023     |    Global Outdoor Lighting Market to Witness 8.4% CAGR during 2017 - 2023     |    Oral Mucositis Therapeutics Pipeline to Receive More Drug Designations from the USFDA in the Coming Years

Toll Free (US/Canada): 1-888-778-7886

INT'L: 1-347-960-6455

enquiry@psmarketresearch.com

Pharmaceuticals Industry Insights

Pharmaceuticals

The players in the pharmaceutical industry include large pharmaceutical manufacturers, speciality pharmaceutical manufacturers, contract research organization and distributors. The pharmaceutical sector is experiencing some positive trends such as improving early-stage product pipelines, mainly for cancer and diabetes drugs and a plethora of new products being introduced. The industry is driven by various key drivers such as ageing population, rise in chronic diseases and rising demand for pharma products in the emerging economies. Apart from various favourable trends, the industry is also faced with various bottlenecks such as intense competition among the generic drug makers, pricing pressures and a comparatively declining level of research and development activity. In order to overcome these bottlenecks, the players in the market need to refocus on their R&D activities and value chain costs.

Research Reports

Price

Lysosomal Storage Disorder Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Lysosomal Storage Disorders Pipeline Analysis report
  • Lysosomal storage disorder refers to inherited metabolic disorders that are characterize by enzyme deficiencies, which results in an abnormal build-up of various toxic materials in the body's cells. There are nearly 50 types of lysosomal storage disorder which affect various parts of the body including the brain, skeleton, heart, central nervous system and skin. Some of the lysosomal storage disorders are Aspartylglucosaminuria, Batten Disease, Cystinosis, Fabry ...Continue Reading

$3250

Spinal Muscular Atrophy (SMA) Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Spinal Muscular Atrophy Therapeutics Pipeline Analysis report
  • Spinal muscular atrophy is a rare inherited genetic disease that is characterized by loss of nerve cells, known as motor neurons. Motor neurons receive the nerve impulses, which are transmitted from the brain to the spinal cord and, further transmits these impulses to the muscles with the help of peripheral nerves. The loss of motor neurons can lead to atrophy and weakness in the muscles, that are closest to the trunk of the body such as back, hips and shoulders. Spinal muscular atrophy is mainly caused due to the mutatio ...Continue Reading

$1850

Hemophilia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Hemophilia Therapeutics Pipeline Analysis report
  • Hemophilia is a genetic disorder characterized by excessive bleeding and delayed blood clotting. There are two types of hemophilia, hemophilia A (also known as classic hemophilia) and hemophilia B. According to the Centers for Disease Control and Prevention, the incidence of hemophilia stands at, one out of every 5,000 male births and as many as 20,000 males in the U.S., living with either of the two types of hemophilia, presently. The prevalence of hemophilia A is around four times high as compared to the prevalence of h ...Continue Reading

$2500

Hepatic Encephalopathy Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Hepatic Encephalopathy Therapeutics Pipeline Analysis report
  • Due to various risk factors the prevalence of hepatic encephalopathy has been increasing globally. The risk factors for the disease include the consumption of alcohol, drugs addiction for sedatives such as benzodiazepines; often used in treatment of anxiety disorders that can suppress the alcohol withdrawal, challenges in the correct diagnosis and other infections, such as jaundice and deficiency of liver enzymes. According to the Journal of Gastrointestinal & Digestive System, studies proves that in developed countri ...Continue Reading

$3250

Inflammatory Bowel Disorder Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Inflammatory Bowel Disorder Therapeutics Pipeline Analysis report
  • Globally, the prevalence of inflammatory bowel disorder has been increasing, mainly due to several risk factors such as high pollution due to rapid establishment of industries, smoking and habitual use of non-steroidal anti-inflammatory medicines. The inflammatory bowel disorder therapeutic pipeline is expected to grow in the future mainly due to the emergence of several novel drugs in the market, since various pharmaceutical and biotechnology companies have been focusing to develop drugs for the treatment of this disease ...Continue Reading

$3250

Fibromyalgia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Fibromyalgia Therapeutics Pipeline Analysis report
  • Fibromyalgia therapeutic pipeline is expected to experience a positive trend in the coming years. Prevalence of fibromyalgia is increasing due to very large number of patients suffering from lifestyle disease, psychological stress, trauma, tension, headaches, anxiety and depression. Some of the significant factors driving the pipeline for fibromyalgia include rising prevalence of fibromyalgia and the increasing health awareness among the population, globally. According to the National Fibromyalgia and Chronic Pain Associa ...Continue Reading

$3250

Diabetic Foot Ulcers Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Diabetic Foot Ulcers Therapeutics Pipeline Analysis report
  • Neuropathy, ischemia (peripheral vascular disease) and foot infection are some of the characteristic features of diabetic foot. According to the International Journal of Diabetes in Developing Countries, around 15% of all diabetic individuals are at high risk of developing diabetic foot ulcers. Barefoot walking, late presentation by patients, and belief in alternative system of medicines are contributing factors to the increasing prevalence of diabetic foot ulcers. Considerable growth in therapeutic pipeline of diabetic f ...Continue Reading

$3250

Ankylosing Spondylitis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Ankylosing Spondylitis Therapeutics Pipeline Analysis report
  • Ankylosing spondylitis is an idiopathic disease, associated with HLA-B27, IL23R and ERAP1 genes. Usually, fewer people get affected with ankylosing spondylitis irrespective of activation of genes. Blood test, X-ray test, Magnetic Resonance Imaging (MRI) and physical investigations are some of the ways to effectively diagnose the disease. The disease begins with the inflammation in joints in the vertebrae and pelvic bones and spine. The environmental factors are believed to be the most important risk factor for increasing ...Continue Reading

$3250

Cataract Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Cataract Therapeutics Pipeline Analysis report
  • Cataract is the clouding of eye lens and it can occur in either one or both the eyes. Cataract is generally more common among people over 80 years of age. According to the National Eye Institute, more than half of the Americans suffer from cataract. Eye lens is transparent and light sensitive and is located at the back of the eye. It helps to focus light rays on retina which aids in the formation of clear image. Images at retina are converted into optic signals that are then communicated to the brain. Eye lens is made up ...Continue Reading

$3250

Post-Traumatic Stress Disorder (PTSD) Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research PTSD Therapeutics Pipeline Analysis report
  • Post-traumatic stress disorder (PTSD) is a neurological disorder that develops in people who have experienced a scary or a dangerous event. PTSD can occur in a person at any age. According to the National Center of PTSD, around seven to eight out of 100 individuals experience PTSD at some point in their lives in the U.S. PTSD generally occurs more often in women than men. It is natural for a person to be feared during or after a traumatic situation, this fear triggers alteration of many split-seconds in the body to defend ...Continue Reading

$2500

Huntington’s Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Huntington Disease Therapeutics Pipeline Analysis report
  • According to the National Institute of Neurological Disorder and Stroke, Huntington’s disease arises from genetically programmed degeneration of neurons in brain which may lead to emotional disturbance, uncontrolled movements or loss of intellectual faculties. This abnormality causes the loss of memory and perception. The increasing growth in the pipeline for Huntington’s disease is primarily attributed to the limited number of treatments available, as well as the technical advancements in medical field which ...Continue Reading

$3250

Mucopolysaccharidosis (Morquio Syndrome) Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Mucopolysaccharidosis Morquio Syndrome Therapeutics Pipeline Analysis report
  • Mucopolysaccharidosis (Morquio Syndrome), is a group of inherited disorder in which body becomes unable to breakdown the mucopolysaccharides. Accumulation of mucopolysaccharides in cells as well as connective tissues causes the malfunctioning of metabolic enzymes. This malfunctioning may lead to occurrence of variety of health problems. Mucopolysaccharidosis is autosomal dominant in most cases involving X-linked pattern of inheritance. The signs and symptoms of the disease varies by the type of mucopolysaccharidosis. Some ...Continue Reading

$3250

Lennox-Gastaut Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Lennox Gastaut Syndrome Therapeutics Pipeline Analysis report
  • Lennox-Gastaut Syndrome is a rare form of epilepsy that occurs in childhood and is characterized by seizures and intellectual disability. Adverse conditions such as injury to brain and its malformation, lack of oxygen to the new-born infants, infections of central nervous system and inherited metabolic or degenerative disorders are responsible for occurrence of Lennox-Gastaut Syndrome. Anti-epileptic medications are the main treatment option for Lennox-Gastaut Syndrome. The medication is often complicated in case of paedi ...Continue Reading

$3250

Narcolepsy Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Narcolepsy Therapeutics Pipeline Analysis report
  • Narcolepsy is a disease that causes prolongation of extreme daytime sleepiness which can leads to muscle weakness and trouble sleeping at night. The complication associated with the disease are cataplexy, hallucinations and sleep paralysis. Due to these complication, the person is at increased risk of developing mental disorders such as schizophrenia. The environmental factors such as toxins that contains heavy metals, pesticides and weed killers and environmental tobacco smoke are thought to be the cause that narcolepsy ...Continue Reading

$3250

Nephrotic Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Nephrotic Syndrome Therapeutics Pipeline Analysis report
  • The growth in the pipeline of nephrotic syndrome is attributed to the increase in prevalence of individuals affected with diabetes, hypertension and hyperlipidaemia. Unhealthy lifestyle and unhygienic crops and fruits are also the factors that are contributing to the growth of therapeutic pipeline of nephrotic syndrome. Environmental factors are also thought to be responsible for occurrence of nephrotic syndrome. Funds from various organizations are contributing to the research and developments in the therapy area which i ...Continue Reading

$3250

Malignant Mesothelioma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Malignant Mesothelioma Therapeutics Pipeline Analysis report
  • Malignant mesothelioma is a rare type of cancer that is characterised by tumor formation in the mesothelium, a tissue layer that covers the pleural organs such as heart, abdomen, lungs and other organs. The biggest risk factor of the disease is exposure to asbestos, a silicate mineral. Some of the major symptoms of the disease include cough, shortness of breath and pain in the chest. The symptoms in malignant mesothelioma could take as long as 30 to 50 years to show. Surgery, chemotherapy and radiotherapy are some of the ...Continue Reading

$3250

Critical Limb Ischemia (CLI) Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Critical Limb Ischemia Therapeutics Pipeline Analysis report
  • Critical limb ischemia (CLI) is a severe peripheral arterial disease (PAD) characterised by blockage in the arteries of the lower limbs, which in turn reduces blood-flow. The primary cause of the disease is atherosclerosis or the buildup of fatty deposits called plaque in the arteries. Other risk factors for the disease include hypercholesterolemia, obesity, smoking, hypertension and diabetes. Diabetes is a significant risk factor because it is often linked with severe PADs. The most common symptoms of CLI are the ischemi ...Continue Reading

$3250

Myelodysplastic Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Myelodysplastic Syndrome Therapeutics Pipeline Analysis report
  • Myelodysplastic syndrome therapeutics pipeline is expected to grow primarily due to the increasing prevalence of the disease as a result of increasing exposure of general population to chemicals and radiation. Some of the main factors driving the pipeline for myelodysplastic syndrome include rising older population, increasing exposure of heavy metals, smoking, tobacco consumption, low market penetration since a limited number of companies are making an analog of marketed drugs and increasing health awareness among people ...Continue Reading

$3250

Glaucoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Glaucoma Therapeutics Pipeline Analysis report
  • Glaucoma is a collection of diseases that injure the optic nerve of the eyes and can eventually lead to loss of vision or complete blindness. People over the age of 60 years, especially Mexican Americans and African Americans and people with a family history of glaucoma are at greater risk of developing glaucoma at some point of time in their lives. It has also been observed that people with blood pressure and heart related problems are more likely to be affected by the condition. As per the estimates of the American Acad ...Continue Reading

$3250

Alopecia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Alopecia Therapeutics Pipeline Analysis report
  • Alopecia is a skin disease characterised by loss of hair on the scalp, face and less frequently on other parts of the body. According to the National Alopecia Areata Foundation, approximately 6.8 million people in the U.S. and about 147 million people globally are affected by the disease and approximately 2.1% people have a lifetime risk of developing the disease. There are many types of alopecia of which male-pattern baldness is the most commonly encountered type that affects around 50% of males by 50 years of age global ...Continue Reading

$3250

Immune Thrombocytopenic Purpura Therapeutics (ITP) Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Immune Thrombocytopenic Purpura Therapeutics Pipeline Analysis report
  • Immune thrombocytopenic purpura (ITP), also known as idiopathic thrombocytopenic purpura, is a blood disorder characterised by weakened functioning of clotting of blood. People with the disease have a tendency to bleed or bruise as a result of a low number platelets or thrombocytes which results from the self-destruction of platelets by body’s own immune system. Some of the risk factors for the disease include viral infection, use of certain drugs during pregnancy or other immune disorder. ITP is more common in wome ...Continue Reading

$3250

Diabetic Nephropathy Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Diabetic Nephropathy Therapeutics Pipeline Analysis report
  • Diabetic nephropathy is a complication of diabetes characterised by damage to the kidneys filtering system. It hampers the ability of kidneys to remove waste products and extra fluid from body. Some of the most common symptoms of diabetic nephropathy include high blood pressure, fatigue, anorexia, headache, skin dryness, and swelling of limbs. The most common risk factors of diabetic nephropathy include diabetes, high blood sugar, high blood pressure, smoking, and heredity. Approximately 40% of people with diabetes eventu ...Continue Reading

$3250

Allergic Conjunctivitis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Allergic Conjunctivitis Therapeutics Pipeline Analysis report
  • Allergic conjunctivitis is a disease characterised by inflammation of eyes due to an allergic reaction to substances such as pollen particles or mold spores. It is a collective term for eye infections such as seasonal allergic conjunctivitis (SAC), vernal keratoconjunctivitis (VKC), perennial allergic conjunctivitis (PAC), and atopic keratocongiuntivitis (AKC). Some of the most common forms of eye allergies are the SAC and PAC. According to a study published in the journal, Recent patents on inflammation and allergy drug ...Continue Reading

$3250

Post Menopausal Osteoporosis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Post Menopausal Osteoporosis Therapeutics Pipeline Analysis report
  • Postmenopausal osteoporosis is a condition affecting millions of women worldwide. It is characterised by decreased bone density in women of postmenopausal age which in turn increases the fragility of bones and making them susceptible to increased risk of sudden and unexpected bone fractures. The cause of postmenopausal osteoporosis is not clearly identified, however, the decrease in bone density is directly linked to deficiency of estrogen, a natural consequence of menopause in women. Since, menopause is an inevitable par ...Continue Reading

$3250

Atrial Fibrillation Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Atrial Fibrillation Therapeutics Pipeline Analysis report
  • Atrial fibrillation therapeutic pipeline is expected to increase on account of increasing prevalence of lifestyle disease such as obesity, diabetes, high blood pressure and cholesterol, which in turn lead to increase in the incidence of the disease. Some other prominent factors driving the pipeline analysis for atrial fibrillation include aging population, growing tobacco and alcohol consumption and rising health awareness among people. According to the recently published data by Centers for Disease Control and Prevention ...Continue Reading

$3250

Acute Kidney Injury Therapeutic Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Acute Kidney Injury Therapeutic Pipeline Analysis report
  • Acute kidney injury therapeutic pipeline is likely to grow on account of increasing incidence of diabetes and high blood pressure, in people, resulting in increasing prevalence of acute kidney injury, globally. Low market penetration, due to presence of limited number of companies making an analog and increasing health awareness among people are few other factors contributing to the growth of acute kidney injury therapeutic pipeline. According to the Centers for Disease Control and Prevention, women (15.93%) are more like ...Continue Reading

$3250

Psoriasis Therapeutic Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Psoriasis Therapeutic Pipeline Analysis report
  • Therapeutic pipeline for analysis of psoriasis is likely to grow on account of increasing prevalence of psoriasis, globally, which is caused due to abnormalities in the immune system caused by external stressors and low market penetration of drugs that can successfully cure the disease. According to the latest data published by the American Academy of Dermatology, approximately 7.5 million people in the U.S. are suffering from psoriasis. The disease is prevalent in people of all age groups, mostly in adults. Both males an ...Continue Reading

$3250

Allergic Rhinitis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Allergic Rhinitis Therapeutics Pipeline Analysis report
  • Allergic rhinitis therapeutics pipeline is likely to grow over next few years, on account of increasing air pollution and unchecked exposure of humans to chemicals and radiations, which lead to increase in the incidence of allergic rhinitis. Poor air quality, low market penetration of effective drugs, as most of the available drugs provide temporary relief, and increasing health awareness among people are few other factors expected to propel growth in the allergic rhinitis therapeutics pipeline. According to the latest da ...Continue Reading

$3250

Paroxysmal Nocturnal Hemoglobinuria Therapeutic Pipeline Analysis, 2017 Clinical Research and Developments

  • P&S Market Research Paroxysmal Nocturnal Hemoglobinuria Therapeutic Pipeline Analysis report
  • Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare life-threatening disease characterized by destruction of red blood cells, blood clots, and compromised bone marrow function. Some of the symptoms of the disease include abdominal and back pain, dark urine, easy bruising or bleeding, fatigue or weakness, headache and shortness of breath. The risk factors for PNH include age, obesity and hormone therapy. According to the Johns Hopkins Medicine, approximately, one to one and a half persons per million of the population are ...Continue Reading

$3250

Hypercholesterolemia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Hypercholesterolemia Therapeutics Pipeline Analysis report
  • Hypercholesterolemia is a disorder characterised by abnormally increased levels of cholesterol in the blood. The high levels of cholesterol increase a person's risk of developing cardiovascular diseases such as coronary artery disease, which involve build-up of plaque in the coronary arteries, in turn putting a person across the risk of suffering a heart attack. The main causes of hypercholesterolemia include heredity, diet high in saturated fats and cholesterol, other diseases such as diabetes mellitus, renal disease ...Continue Reading

$3250

Niemann–Pick Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Niemann Pick Disease Therapeutics Pipeline Analysis report
  • Niemann-Pick Disease is a type of lipid storage disorder characterised by accumulation of fatty substances in organs such as spleen, liver, and brain, eventually causing cell death resulting in malfunctioning of major organ systems. Its pathogenesis involves deficiency of a lysosomal enzyme called acid sphingomyelinase, and is mainly caused by genetic mutation. Niemann-Pick disease is majorly prevalent in North America, South America, Europe, Africa, Asia, and Australia. There are three main types of Niemann-Pick Disease ...Continue Reading

$3250

Dry Eye Syndrome Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Dry Eye Syndrome Therapeutics Pipeline Analysis report
  • Dry eye syndrome, also known as dry eye disease, keratitis sicca and keratoconjunctivitis sicca, is a form of ocular surface and tears disease that results in problems in vision, discomfort and tear film instability, causing potential damage to the ocular surface. It can also overlap with other causes of ocular surface disease such as meibomian gland dysfunction and ocular allergy. The ocular surface consists of seven components including the lacrimal and accessory lacrimal apparatus, the tear film, the nasolacrimal drain ...Continue Reading

$2500

Oral Mucositis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Oral Mucositis Therapeutics Pipeline Analysis report
  • Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The diseas ...Continue Reading

$1850

Age-Related Macular Degeneration Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Age Related Macular Degeneration Therapeutics Pipeline Analysis report
  • Age-related macular degeneration is a disorder that causes loss of vision in a person due to macula damage; macula is that part of an eye, which helps a person to see, it is made up of millions of light-sensing cells which provide sharp and central vision. Age-related macular degeneration progresses slowly in an individual and can eventually lead to blindness. The most common symptom of Age-related macular degeneration is blurry vision. ...Continue Reading

$2500

Synovial Sarcoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Synovial Sarcoma Therapeutics Pipeline Analysis report
  • Synovial sarcoma is rare type of cancer and approximately one to three people in every million people are diagnosed with synovial sarcoma every year, globally. The disease occurs frequently in young adults; however, the disease can affect people at any age. Synovial sarcoma is more common in males, and the ratio of the disease stands at 12 males for every ten females. Synovial sarcoma often begins in the legs or arms; however, it can affect any area of the body. The disease is categorized in different subtypes based on mi ...Continue Reading

$2500

Candidiasis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Candidiasis Therapeutics Pipeline Analysis report
  • Candidiasis is a very common type of fungal infection caused by fungus known as candida. Candida is usually found in various parts of our body including mouth, skin or belly and cause no harm. It is only when this fungus gets right environment it multiplies and grows uncontrollably. This condition results in occurring of the infection, known as candidiasis. There are various different types of candidiasis like thrush (oropharyngeal candidiasis), genital yeast infection (genital candidiasis), diaper rash from yeast infecti ...Continue Reading

$1850

Uveitis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Uveitis Therapeutics Pipeline Analysis report
  • Uveitis is a chronic inflammatory disease which causes swelling and pain in eye tissues, mainly uvea. It also affects the retina, lens, vitreous and optic nerve, thus hampering the vision of a person. The chances of vision being affected depends on the severity of the disease. People in the age group of 20 to 60 years are most affected by this disease. The severity of the disease can vary from acute to chronic. The different types of uveitis based on the location of the affected tissue includes anterior uveitis, intermedi ...Continue Reading

$2500

Diabetic Macular Edema Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Diabetic Macular Edema Therapeutics Pipeline Analysis report
  • As estimated worldwide in 2011, the number of peoples with diabetes were around 346 million and its number is unceasingly getting bigger. It is expected to be double in number by 2030. Diabetic retinopathy and diabetic macular edema is occurring, which leads to the vision loss. These adverse conditions mostly occur in patient having high blood sugar level and high blood pressure. Therefore, the consequential increase in growth of diabetic macular edema therapeutics pipeline is observed. ...Continue Reading

$3250

Congestive Heart Failure Therapeutics Pipeline Analysis, 2017 - Clinical Trials and Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Congestive Heart Failure Therapeutics Pipeline Analysis report
  • Prevalence of congestive heart failure is witnessed to have increased, especially in Asia-Pacific and American region, due to rapid change in lifestyle of people, which in turn is results in various lifestyle diseases such as diabetes and high blood pressure. Additionally, other factors such as, sedentary nature of job, high cholesterol diet intake, lack of exercise, pollution, are also contributing to the increasing incidence of congestive heart failure, across the globe. The therapeutic pipeline for congestive heart fai ...Continue Reading

$3250

Cluster Headache Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Cluster Headache Therapeutics Pipeline Analysis report
  • Rapidly increasing pace of life, change in lifestyle, higher stress levels, etc., are few of the major factors to which the increasing prevalence of cluster headache scan be attributed. Further, unhealthy dietary intake, smoking, alcoholconsumption and growing levels of pollutionare few other factors which are expected to fuel the incidence of cluster headache problem. The Therapeutic pipeline of cluster headache is expected to grow in future with the participation of various pharmaceutical companies that are focusing on ...Continue Reading

$3250

Asthma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Asthma Therapeutics Pipeline Analysis report
  • The pipeline for asthma therapeutics is expected to experience a positive trend in the future, the increase is mainly attributable to decreasing air quality. The prevalence of asthma is increasing globally due to the factors including environmental factors, genetic factors, air pollution, less physical activity and smoking. These factors contribute immensely in driving the pipeline analysis for asthma. According to World Health Organization, around 235 million people suffered from asthma, in 2013. Asthma related deaths oc ...Continue Reading

$3250

Global Biosimilars Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Biosimilars Market report
  • Biosimilars are complex biological products made from living organism that include microorganisms such as bacteria and yeast, humans, and animals. These biological products are similar biological product also known as biological reference product, that have been approved by the U.S. Food Drug and Administration (USFDA). Biosimilars are compared with the biological reference products and licensed by the USFDA. Patent expiration of biological reference product is the key factor leading to development of biosimilars. These a ...Continue Reading

$5100

Insomnia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Insomnia Therapeutics Pipeline Analysis report
  • Insomnia therapeutic pipeline analysis is expected to experience vast growth in future, with the increasing level of stress being the major contributor for the rising prevalence of the disease. Some of the other major factors driving the pipeline for insomnia include lifestyle diseases, smoking, alcohol and tobacco consumption and increasing health awareness. According to the data by American Academy of Sleep Medicine, every year eight million people suffer from insomnia in the U.S. It is believed that the disease is more ...Continue Reading

$3250

Glioma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Glioma Therapeutics Pipeline Analysis report
  • The pipeline for glioma therapeutics is expected to experience rising research activities in future due to raise in funding by the orphan disease organization such as, National Organization of Rare Disorders. Many novel therapies such as, gene therapies, cell therapies are being developed for the treatment of glioma. Various technological advancements in research and development techniques is also be one of the key factors leading to the upsurge in the growth of glioma pipeline therapeutics. Additionally, increasing aware ...Continue Reading

$3250

Acute coronary syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Acute coronary syndrome Therapeutics Pipeline Analysis report
  • The Acute coronary syndrome pipeline therapeutics pipeline is expected to increase on account of increasing population, which are at risk of severe cardiovascular disease. High blood pressure, uncontrollable blood sugar level, hypercholesterolemia, smoking are the main causes of developing acute coronary syndrome. Sometimes, stroke, emotional trauma also make a platform for emerging abnormalities in cardiovascular system. Amendments in lifestyle, routine and habit makes a big difference for increasing continuum of cardiov ...Continue Reading

$3250

Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research COPD Therapeutics Pipeline Analysis report
  • Chronic obstructive pulmonary disease (COPD) is a broad term used for progression of various diseases affecting the lungs such as, chronic bronchitis, some forms of bronchiectasis, emphysema and refractory (non-reversible) asthma. Breathlessness and coughing are few of the early symptoms that induce the hypothesis of having COPD, but some people also consider these symptoms as the signs of aging. In no time, these ailments come under severe progression and reveal the rising of other associated diseases. The primary diagno ...Continue Reading

$2500

Gastrointestinal Stromal Tumor (GIST) Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Gastrointestinal Stromal Tumor Pipeline Analysis report
  • The gastrointestinal stromal tumor (GIST) pipeline will rise with various collaborations and R&D investments. Hereditary risk and genetic factors play an important role in the development of gastrointestinal stromal tumor. Increasing family history of the disease and genetic factors associated with gastrointestinal stromal tumor and low penetration in the market are contributing towards the development of the pipeline. Additionally, increasing awareness regarding various health issues among people is another major fac ...Continue Reading

$3250

Bronchitis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Bronchitis Therapeutics Pipeline Analysis report
  • Bronchitis therapeutic pipeline is likely to experience a positive trend in future due to decreasing quality of the air and increasing smoking. Prevalence of bronchitis is increasing due to environmental factors, genetic factors, infections, industrial pollution, less physical activity and smoking. Some of the main factors driving the pipeline analysis for bronchitis include increasing treatment cost, increasing high rate of hospitalizations due to chronic bronchitis, increasing alpha-1-antitrypsin (AAt) deficiency, low m ...Continue Reading

$3250

Nasopharyngeal Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Nasopharyngeal Cancer Therapeutics Pipeline Analysis report
  • Nasopharyngeal cancer therapeutic pipeline analysis is likely to grow mainly due to the rising prevalence of nasopharyngeal cancer, globally. Some of the main factors driving the pipeline analysis for nasopharyngeal cancer includes increasing geriatric population, rising tobacco and alcohol consumption and increasing prevalence of nasopharyngeal cancer, untapped market as being a rare form of head and neck cancer and increasing health awareness. According to American Cancer Society, the nasopharyngeal cancer is more commo ...Continue Reading

$3250

Graves Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Graves Disease Therapeutics Pipeline Analysis report
  • Graves disease therapeutic pipeline analysis is expected to increase owing to the high prevalence of the disease. Growing number of cases for hyperthyroidism is a major factor driving the pipeline analysis for Graves disease . In addition, increasing awareness regarding health issues among people is another major factor contributing towards the pipeline for Graves disease. According to American Thyroid Association, the prevalence of Graves disease has increased with increasing hyperthyroidism patients. ...Continue Reading

$3250

Chronic Heart Failure Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Chronic Heart Failure Therapeutics Pipeline Analysis report
  • Chronic heart failure therapeutic pipeline will increase in near future due to increasing cases of the disease. The prevalence of chronic heart failure is increasing globally due to the factors including obesity, diabetes, high blood pressure, cholesterol, less physical activity and tobacco consumption. These factors are contributing in driving the pipeline analysis for chronic heart failure. According to Centers for Disease Control and Prevention, around 5.7 million adults in the U.S. have heart failure and about half of ...Continue Reading

$3250

Juvenile Idiopathic Arthritis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Juvenile Idiopathic Arthritis Therapeutics Pipeline Analysis report
  • The expanding pipeline for juvenile idiopathic arthritis can be attributed to the increase in its prevalence. One of the major factor that stimulate the growth of pipeline and research is that the cause of juvenile idiopathic arthritis is not known. The juvenile idiopathic arthritis occurs mostly in children before 16 years of age. Since the disease occurs only in children, so the safety and efficacy concerns of the drugs is given preference so that it can be treated without any side effects. Some of the other factors dri ...Continue Reading

$3250

Psoriatic Arthritis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Psoriatic Arthritis Therapeutics Pipeline Analysis report
  • The number of drug candidates in pipeline for psoriatic arthritis are expected to increase on account of increase in the prevalence of psoriasis, globally. Psoriasis is the skin disease which is more common in Caucasian as compared to the African American and Asian Americans. The disease is symptomatized by white and scaly red patches. The prevalence of psoriatic arthritis has been increasing mainly in the patients, who are more susceptible to infection that may activate their immune system. Increase in mortality rate, ot ...Continue Reading

$3250

Cushing’s Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Cushing Syndrome Therapeutics Pipeline Analysis report
  • The expending growth of pipeline for Cushing’s syndrome therapeutics is attributed to the increase in prevalence of inflammatory disorders. For the treatment of various inflammatory disorders patients use corticosteroids, the long-term use of corticosteroids can lead to Cushing’s syndrome. In many diseases such as asthma and rheumatoid arthritis, corticosteroids are being used, for a lifelong period but at low doses. However, when the disease fails to respond to lower doses of corticosteroids, the dose needs t ...Continue Reading

$3250

Chronic Kidney Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Chronic Kidney Disease Therapeutics Pipeline Analysis report
  • The therapeutics pipeline of chronic kidney disease has been increasing on account of rising prevalence of diabetes and high blood pressure in patients. The diabetes and blood pressure are the main causes of chronic kidney disease, which is also related to cardiovascular disease. Due to altered lifestyle, the chances of incidence of high blood pressure and diabetes is on a rise. Currently, the prevalence of chronic kidney disease is around 14% in Australia, as studied by Oxford Academic Journal of Nephrology Dialysis Tran ...Continue Reading

$3250

Hereditary Angioedema Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Hereditary Angioedema Therapeutics Pipeline Analysis report
  • The pipeline of hereditary angioedema is increasing on account of rising instances of angioedema, globally. Currently, an estimated prevalence of hereditary angioedema in the world is 1 in 10,000 to 1 in 150,000. Major factors driving the growth of pipeline for hereditary angioedema include increasing prevalence of attacks of angioedema and rising cases of angioedema in association with other conditions like significant hypotension resulting from abdominal attacks, low market penetration as very less number of companies a ...Continue Reading

$3250

Multiple Sclerosis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Multiple Sclerosis Therapeutics Pipeline Analysis report
  • Multiple sclerosis therapeutic pipeline is expected to grow in future on account of increasing demands of drugs which can completely overcome the rising prevalence of the disease. Currently, multiple sclerosis is mainly impacting regions North America and Europe, some of the other geographies impacted with the disease include Eastern Asia and Sub-Saharan Africa, at very low rate. Major factors driving the growth of pipeline for multiple sclerosis are increasing incidences of multiple sclerosis, stress conditions related t ...Continue Reading

$3250

Polycystic Kidney Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Polycystic Kidney Disease Therapeutics Pipeline Analysis report
  • The platform of new drugs for the polycystic kidney disease is increasing on account of less number of drugs available for treatment of the disease. Polycystic kidney disease is a form of rare disease and the drugs which are available for treatment, have an adverse effect on the health of patients. Currently, the prevalence of polycystic kidney disease in the U.S. ranges from 1 in 400 to 1 in 1000 which resulted in end stage renal disease by the age of 53. Around 600,000 patients are suffering from renal disease, out of w ...Continue Reading

$3250

Fabry Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Fabry Disease Therapeutics Pipeline Analysis report
  • Fabry disease is a type of inherited genetic disease caused due to abnormal deposition of a fatty substance, called globotriaosylcera-mide, in blood vessel walls throughout the body. This further leads to development of other complications, which result in severe morbidities and can also be fatal, in some cases. Anticipated growth of therapeutic pipeline of fabry disease can be attributed to the rareness of the disease, as it is usually found in males at an estimated ratio of one in 40,000 to 60,000 males. Although, the d ...Continue Reading

$3250

Peripheral Arterial Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Peripheral Arterial Disease Therapeutics Pipeline Analysis report
  • On account of increasing number of cases related to high blood pressure and diabetes, growth in pipeline of peripheral arterial disease is anticipated in the next few years. One of the main causes of peripheral arterial disease is smoking, which leads to the building up of plaque inside the arteries that carry oxygen rich blood. As per the data provided by World Health Organization in 2015, nearly 1.1 billion people were addicted to smoking. Moreover, increasing number of people are being diagnosed with high blood pressur ...Continue Reading

$3250

Myelofibrosis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Myelofibrosis Therapeutics Pipeline Analysis report
  • Myelofibrosis is a disease characterized by the build-up of scar tissue in the bone marrow, which leads to genetic mutation in a person’s body. The myelofibrosis therapeutics pipeline is anticipated to increase with the growing need to develop a cure for the problem, and is noticed in approximately one in 500,000 people, in the U.S., usually in the age group of 50 to 80 years, as per the as data provided by U.S. national Library of Medicine. It is a rare form of disease and also happens to patients with thrombocythe ...Continue Reading

$3250

Herpes Simplex Virus (HSV) Infections Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research HSV Infections Therapeutics Pipeline Analysis report
  • Herpes is an infection caused by a virus known as, herpes simplex virus. It is estimated, that around 3.7 billion people under the age of 50 years are suffering with the herpes simplex virus infection, globally. The disease is categorized into two types: HSV1 and HSV2. HSV1, also known as oral herpes can lead to sores on the mouth and around the lips, HSV2 causes genital herpes. A person can get infected with HSV1 by sharing lip balm, kissing and eating from the same utensils. HSV2 spreads through sexual contact with a pe ...Continue Reading

$1850

Amyotrophic Lateral Sclerosis (ALS) Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Amyotrophic Lateral Sclerosis Pipeline Analysis report
  • Amyotrophic lateral sclerosis is a disease that causes progression in neurodegeneration in brain and spinal cord. In Amyotrophic lateral sclerosis, the muscle does not get adequate nourishment due to which it becomes atrophic. The disease occurs in the lateral region, an area in which spinal cord reflexes are found majorly. Therefore, the degeneration leads to hardening and scarring of muscles in that region. The progressive degeneration of neurons from brain to the spinal cord and spinal cord to the whole body can ultima ...Continue Reading

$2500

Myasthenia Gravis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Myasthenia Gravis Therapeutics Pipeline Analysis report
  • Myasthenia gravis is a neuromuscular disease that leads to varying degrees of skeletal muscle weakness. It is an autoimmune disease resulting from the antibodies blocking or destroying nicotinic acetylcholine receptors at the junction between the nerve and muscle, thus preventing nerve impulses rom triggering muscle contractions. Growth is anticipated in the myasthenia gravis therapeutics pipeline on account of increasing participation of organizations, such as National Organization for Rare Disorder, that support researc ...Continue Reading

$3250

Small Lymphocytic Lymphoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Small Lymphocytic Lymphoma Therapeutics Pipeline Analysis report
  • The rising prevalence of small lymphocytic lymphoma is responsible for the upsurge in research and development of therapeutics that can control progression of the disease, and in turn lead to discovery of new targets that would assist in curing cancer. Increasing adoption of unhealthy lifestyle, unchecked use of pesticides in cultivating crops and fruits along with intake of unhygienic food items causes virus infection such as Hepatitis C and Epstein-Barr virus, which may trigger the incidence of small lymphocytic lymphom ...Continue Reading

$3250

Chronic Inflammatory Demyelinating Polyneuropathy Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Chronic Inflammatory Demyelinating Polyneuropathy Therapeutics Pipeline Analysis report
  • Chronic inflammatory demyelinating polyneuropathy pipeline is expected to grow in the next few years on account of increasing prevalence of the disease, which is noticed by progressive muscle weakness, loss of deep tendon reflexes, abnormal sensations, etc. According to a study conducted by American Association of Neuromuscular & Electrodiagnostic Medicine, around 40,000 people in the U.S. get affected from the disease, every year. High prevalence of chronic inflammatory demyelinating polyneuropathy is in turn compell ...Continue Reading

$3250

Clostridium Difficile-Associated Diarrhea (CDAD)Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Clostridium Difficile Associated Diarrhea Therapeutics Pipeline Analysis report
  • The prevalence of clostridium difficile associated diarrhea has been increasing all across the world on account of unchecked use of antibiotics and laxatives by people, which creates a suitable medium for the growth of the bacteria. Clostridium Difficile is a commonly noticed disease in people above 65 years of age, as they tend to consume antibiotics and laxatives for easy and effective bowel movement. The therapeutic pipeline of clostridium difficile associated diarrhea is growing with the involvement of various pharmac ...Continue Reading

$3250

Fragile-x Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Fragile x Syndrome Therapeutics Pipeline Analysis report
  • Due to lack of awareness among people regarding genetic disorders which leads to mutations in one’s DNA, the prevalence of fragile-x syndrome is increasing, across the globe. Smoking, alcohol consumption during pregnancy and hereditary disorders are few of the primary reasons to for the increase in prevalence of fragile-x syndrome. The therapeutic pipeline of fragile-x syndrome is expected to grow more rapidly in the future on account of active involvement of pharmaceuticals & biotechnology companies carrying ou ...Continue Reading

$3250

Cystic Fibrosis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Cystic Fibrosis Therapeutics Pipeline Analysis report
  • Increasing prevalence of cystic fibrosis being witnessed mostly in Europe and the U.S. due to lack of awareness among people towards genetic diseases. In addition, some other factors contributing to the increasing occurrence of cystic fibrosis disease include smoking during pregnancy, hereditary disorder, and premature mortality of infants. The therapeutic pipeline of this particular disease is expected to grow in the future on account of major pharmaceutical companies betting involved in research & development of per ...Continue Reading

$3250

Systemic Lupus Erythematosus Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Systemic Lupus Erythematosus Pipeline Analysis report
  • Systemic lupus erythematosus is a chronic inflammatory disease that involves swelling and pain, most commonly on face. The disease affects many parts of the body including skin, joints, kidneys, pleura, pericardium and brain. The systemic lupus erythematosus is caused by impaired immune system due to which the immune system attacks its own tissues and can cause widespread inflammation and tissue damage in the affected organs. As of now there is no cure for systemic lupus erythematosus, but medical interventions and lifest ...Continue Reading

$2500

Anal Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Anal Cancer Therapeutics Pipeline Analysis report
  • Anal cancer therapeutic pipeline analysis is expected to increase owing to increasing incidence globally, majorly in older adults. Major factors driving towards the pipeline growth for anal cancer include growing rate of sexually transmitted diseases and aging population. Additionally, increasing awareness regarding health issues among people is another major factor fueling the pipeline growth for anal cancer. According to American Cancer Society, the ...Continue Reading

$3250

Chronic Myelocytic Leukemia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Chronic Myelocytic Leukemia Therapeutics Pipeline Analysis report
  • Chronic myelocytic leukemia therapeutic pipeline analysis is expected to grow rapidly due to the increasing prevalence of the disease, globally. Some of the main factors driving the pipeline analysis for chronic myelocytic leukemia include increasing aging population and rising prevalence of chronic myelocytic leukemia, and increasing health awareness. Chronic myelocytic leukemia have high incidence rate in men and is the second most common type ...Continue Reading

$3250

Ewing Sarcoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments

  • P&S Market Research Ewing sarcoma Therapeutics Pipeline Analysis report
  • Ewing sarcoma is a condition in which formation of cancer or tumor takes place in the bones and soft tissues. It is the second most common type of primary sarcoma found in young adults and children. Ewing sarcoma occurs in ribs, long bones, spine (vertebral column) and pelvis. The prevalence of Ewing sarcoma has increased in the past few years, but the exact cause of the disease is still unknown; some of the risk factors that increase the probability of occurrence of Ewing sarcoma include genetic changes (translocation be ...Continue Reading

$1850

Ulcerative Colitis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments

  • P&S Market Research Ulcerative Colitis Pipeline Analysis report
  • Ulcerative colitis is a chronic inflammatory disease, which basically affects colonic mucosa. The main identified symptoms of the disease are bloody diarrhea, abdominal cramps and fatigue. Some of the other symptoms include, fever, vomiting, anorexia, abdominal distension and bloating. The leading cause of ulcerative colitis is the imbalance in regulation of gastrointestinal immune system. According to the International Society for Pharmacoeconomic and Outcomes Research journal named as value in health, the prevalence of ...Continue Reading

$2500

Bipolar Disorder Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Bipolar Disorder Therapeutics Pipeline Analysis report
  • Bipolar disorder therapeutic pipeline analysis is expected to increase on account of increasing instances of issues related to depression and other mental disorders, across the world. Major factors driving the pipeline analysis for bipolar disorder are obesity, stress, incidence of nervous system trauma, depression, low market penetration of medicines as very small number of companies are making an analog. In addition, increasing awareness regarding ...Continue Reading

$3250

Diabetic Gastroparesis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Diabetic Gastroparesis Therapeutics Pipeline Analysis report
  • Diabetic Gastroparesis therapeutic pipeline analysis is expected to grow as observed by the current situation of increasing prevalence of diabetes, globally. Major factors driving the pipeline analysis for diabetic gastroparesis include obesity, incidence of diabetes mellitus, stress conditions and gastroesophageal reflux disease. As there are very limited number of companies are making an analog for treatment and increasing awareness about health issues are ...Continue Reading

$3250

Myocardial Infarction Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Myocardial Infarction Therapeutics Pipeline Analysis report
  • The myocardial infarction therapeutics pipeline is expected to increase in future due to rise in prevalence of myocardial infarction. Myocardial infarction is also commonly known as heart attack which is symptomatized by decrease in blood supply to the heart muscle due to coronary artery disease. According to American Heart Association, the mortality rate due to cardiovascular disease is higher than other disease. According to British Heart Foundation, in 2015 ...Continue Reading

$3250

Neuroblastoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Neuroblastoma Therapeutics Pipeline Analysis report
  • The neuroblastoma therapeutics pipeline is expected to witness considerable growth in the future due to high prevalence of tumour in children. According to the American Cancer Society, around 7.0% of total cancer cases occurred in the age group of 0 to 14, observed as neuroblastoma, with most of the cases being reported at an age of 2 to 3 years. There are various immunotherapies and targeted drug therapies that are being developed for treatment of  ...Continue Reading

$3250

Pulmonary Arterial Hypertension Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Pulmonary Arterial Hypertension Therapeutics Pipeline Analysis report
  • The pulmonary arterial hypertension therapeutics pipeline is expected to increase in over next few years due to increasing prevalence of pulmonary arterial hypertension. Pulmonary arterial hypertension causes difficulty in blood supply to the lungs due to stiffness, tightening or blockage of a pulmonary artery. Some of the drivers for the growth of pulmonary arterial hypertension therapeutics pipeline include increasing incidence of vascular disease, change in ...Continue Reading

$3250

Diabetic Retinopathy Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Diabetic Retinopathy Therapeutics Pipeline Analysis report
  • Diabetic retinopathy therapeutic pipeline analysis is projected to grow as perceived by the current situation of increasing prevalence of diabetes, globally. Some of the main factors driving the pipeline analysis for diabetic retinopathy include obesity, incidence of diabetes mellitus, stress conditions and increasing prevalence of diabetic retinopathy, low market penetration since a limited number of companies are making an analog and increasing ...Continue Reading

$3250

Growth Hormone Deficiency Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Growth Hormone Deficiency Therapeutics Pipeline Analysis report
  • Growth hormone deficiency (GHD) therapeutics pipeline is predicted to increase in future mainly due to the increasing prevalence of the disease, globally. The major factors driving the pipeline of growth hormone deficiency include, increasing prevalence of pituitary dysfunction, low market penetration as very limited number of companies are making an analog of growth hormone. The rising affordability of the drugs and increasing geriatric population also serve ...Continue Reading

$3250

Hodgkin’s Lymphoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Hodgkins Lymphoma Therapeutics Pipeline Analysis report
  • The Hodgkin’s lymphoma therapeutics pipeline is expected to witness considerable growth in the coming years as the researchers are making novel drug delivery system for the treatment for cancer. The government agencies such as National Cancer Institute and American Cancer Society are supporting the growth of the Hodgkin’s lymphoma (HL) therapeutics pipeline by providing funding, designations and grants for speeding up the drug development ...Continue Reading

$3250

Multiple Myeloma (MM) Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Multiple Myeloma Therapeutics Pipeline Analysis report
  • The multiple myeloma therapeutics pipeline is expected to witness considerable growth in the coming year due to high prevalence of the disease. The growth of multiple myeloma therapeutics pipeline is assisted by targeted therapy and new effective treatment. Also, increased awareness among the population about the various cancer treatments has further fueled the growth of the therapeutics pipeline. Increasing healthcare expenditure and ...Continue Reading

$3250

Thyroid Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Thyroid Cancer Therapeutics Pipeline Analysis report
  • The thyroid cancer therapeutics pipeline is expected to witness considerable growth due to increase in the demand for the targeted drug formulation for the treatment of cancer. Though less number of drugs are available for thyroid cancer treatment, an increasing awareness regarding cancer treatment and high demand for safe and effective medications are driving the therapeutics pipeline. ...Continue Reading

$3250

Atopic Dermatitis Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Atopic Dermatitis Pipeline Analysis report
  • The pipeline for atopic dermatitis therapeutic is expected to witness significant growth in the future due to rising prevalence of the disease and food allergies, which is expected to impact around 20.0% of the global population in the developed countries, according to a research done by Nutrition and Health Department, Nestle Research Centre, in 2015. Many generic drugs are already being given, but with the introduction of biologics, particularly ...Continue Reading

$3250

Acute Respiratory Distress Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Acute Respiratory Distress Syndrome Therapeutics Pipeline Analysis report
  • The acute respiratory distress syndrome therapeutics pipeline is expected to witness nominal growth in the coming year due to the slow research and development activities of the pipeline drugs. Some of the factors driving the growth of the pipeline include approval of new therapies that include but are not limited to, tissue factor antagonists, cluster of differentiation modulators, p38 kinase inhibitors and DNA polymerase inhibitors. Also, increasing awareness ...Continue Reading

$3250

Crohn’s Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Crohns Disease Therapeutics Pipeline Analysis report
  • The Crohn’s disease therapeutics pipeline is expected to witness extensive growth in the coming year due to emerging biosimilars and novel treatments. In addition, increasing number of pipeline drugs, rising demand for better medications, high prevalence of Crohn’s disease, involvement of the regulatory bodies for funding and designation and increase in the government agencies for the healthcare expenditure act as the major drivers for the Crohn’s disease therapeutics. ...Continue Reading

$3250

Cytomegalovirus (CMV) Infection Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Cytomegalovirus Infection Therapeutics Pipeline Analysis report
  • The rising number of the research and development activities for the pipeline drugs acts as drivers for the cytomegalovirus infection therapeutics pipeline. The prophylaxis treatment of cytomegalovirus is also increasing due to its effective and safe treatment. The U.S. Food and Drug Administration (USFDA) and European Medicines Agency (EMA) are supporting the cytomegalovirus infection therapeutics pipeline by encouraging the drug development process ...Continue Reading

$3250

Fallopian Tube Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Fallopian Tube Cancer Therapeutics Pipeline Analysis report
  • The fallopian tube cancer therapeutics pipeline is a major focus for the pharmaceutical companies and researchers since it is one of the most debilitating women’s disease. The invention of novel drug delivery and the targeted therapy is expected to drive the pipeline growth for fallopian tube cancer. Increasing awareness regarding cancer treatment, advancement in technologies, high demand for safe and effective medications and high prevalence of ...Continue Reading

$3250

Gallbladder Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Gallbladder Cancer Therapeutics Pipeline Analysis report
  • Gallbladder cancer therapeutics pipeline is expected to witness increased growth in the future since very less number of drugs are available in the pipeline for the treatment of gallbladder cancer. There is an increase in awareness towards cancer treatments, increasing demand for safe and effective medicines, rising healthcare expenditure and technological advancements are supporting the growth of the gallbladder therapeutics pipeline. ...Continue Reading

$3250

Kaposi sarcoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Kaposi sarcoma Therapeutics Pipeline Analysis report
  • The kaposi sarcoma therapeutics pipeline is expected to grow rapidly as the disease also has the risk of the patient being infected with Acquired Immune Deficiency Syndrome (AIDS). AIDS is the most common risk factors of kaposi sarcoma, which develops in people who are infected with HIV. The Kaposi sarcoma therapeutics pipeline is expected to generate large revenue due to increasing awareness regarding cancer treatments, high demand for safe and ...Continue Reading

$3250

Venous Thromboembolism Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Venous Thromboembolism Therapeutics Pipeline Analysis report
  • The venous thromboembolism therapeutics pipeline is expected to witness considerable growth in the coming year due to the development of novel oral anticoagulants as a reasonable and established treatment option. The regulatory bodies are supporting the drug development process through different types of designations and funding. The pipeline is being driven by different factors such as increasing awareness regarding the venous thromboembolism ...Continue Reading

$3250

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments

  • P&S Market Research Phosphoinositide 3 Kinase Inhibitor Pipeline Analysis report
  • Phosphatidylinositol 3-kinases (PI3K) are lipid kinases that play a vital role in cell regulation, including cell survival, proliferation and differentiation. They act as intermediate molecules in PI3K/AKT/mTOR signaling pathway by sending chemical messengers from cell surface to cytoplasm. These signals activate multiple effector kinase pathways, including protein kinase B, bruton's tyrosine kinase and protein kinase C pathway, which result in survival and growth of normal cells. Recent cancer studies have shown that ...Continue Reading

$2500

IgA Nephropathy Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research IgA Nephropathy Pipeline Analysis report
  • Immunoglobulin A Nephropathy, also known as IgA nephropathy (IgAN) or Berger’s disease, is a kidney disorder that arises when IgA builds up in the kidneys, resulting in inflammation which causes damage to kidney tissues. IgA is an immunoglobulin A antibody produced by immune system for body protection from foreign substances such as viruses or bacteria. Production of IgA deposits damages the glomeruli and this results in blood and protein in urine. This progresses over time and eventually results in end stage renal ...Continue Reading

$1850

Sjögren’s Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments

  • P&S Market Research Sjogrens Syndrome Therapeutics Pipeline Analysis report
  • Sjögren’s syndrome is a chronic, autoimmune disease identified by lymphocytic infiltration of exocrine glands and epithelia, which leads to sicca symptoms of dry eyes and dry mouth, and objective evidence of keratoconjunctivitis sicca and xerostomia. Sjogren’s syndrome can be present as primary Sjogren’s syndrome, as itself, or as secondary Sogren’s syndrome, in association with underlying immune conditions. Clinical presentation can vary considerably from relatively mild sicca symptoms, fatig ...Continue Reading

$2500

Global Testicular Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Testicular Cancer Therapeutics Market report
  • Global testicular cancer therapeutics market is growing with the increasing prevalence of testicular cancer. The market is expected to witness moderate growth, since there are already more than 15 drugs that exist in the market for the treatment of testicular cancer. Increasing prevalence of cancer and rising demand for the medications with better efficacy and less side effects can be attributed as an opportunity for oncology. The regulatory bodies such as ...Continue Reading

$5100

Global Acute Lymphoblastic Leukemia (ALL) Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Acute Lymphoblastic Leukemia Therapeutics Market report
  • The global acute lymphoblastic leukemia therapeutics market is expected to witness considerable growth in the coming year since new drug formulations are proving to be the most effective treatment for cancer. An increasing awareness regarding cancer treatment, various technological advancements, high demand for safe and effective medications and high prevalence of cancer, are driving the growth of the global acute lymphoblastic leukemia therapeutics ...Continue Reading

$5100

Global Acute Myeloid Leukemia (AML) Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Acute Myeloid Leukemia Therapeutics Market report
  • The global acute myeloid leukemia therapeutics market is expected to witness notable growth, in the coming year due to increase in the new innovative and targeted drug delivery system. Various factors such as rising awareness regarding cancer treatments, increasing demand for safe and successful medications, rising incidence of cancer and technological advancements have been driving the growth of the global acute myeloid leukemia therapeutics ...Continue Reading

$5100

Global Chronic Lymphocytic Leukemia (CLL) Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Chronic Lymphocytic Leukemia Therapeutics Market report
  • The global chronic lymphocytic leukemia therapeutics market is expected to create more opportunities in oncology due to promising pipeline and positive clinical data of drug candidates. The existing drugs for the treatment of chronic lymphocytic leukemia is the be most effective treatment. The American Cancer Society, and other regulatory bodies are supporting the chronic lymphocytic leukemia therapeutics market by providing funding and grants. ...Continue Reading

$5100

Global Benign Prostatic Hyperplasia Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Benign Prostatic Hyperplasia Therapeutics Market report
  • The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding ...Continue Reading

$5100

Global Endometrial Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Endometrial Cancer Treatment Market report
  • Global endometrial cancer therapeutics market is expected to witness significant growth as there are less number of approved drugs for treatment of endometrial cancer, leading to an increased opportunity for the drug manufacturers. High prevalence of cancer and rising demand for safe and effective medications can be attributed as the major drivers of this market. The regulatory bodies such as USFDA and EMA are supporting the growth of the global ...Continue Reading

$5100

Global Esophageal Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Esophageal Cancer Therapeutics Market report
  • Global esophageal cancer therapeutics market is expected to witness significant growth with an increasing awareness regarding cancer treatment and technological advancements. Also, high demand for safe and effective medications and rising prevalence of cancer are driving the growth of the global market. The regulatory bodies such as USFDA, EMA are supporting the growth of the global market by providing funding, designations and grants for speeding up the drug development process. ...Continue Reading

$5100

Global Neuroendocrine Carcinoma Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Neuroendocrine Carcinoma Therapeutics Market report
  • Global neuroendocrine carcinoma therapeutics market is witnessing significant growth due to large number of marketed drugs and Phase III drugs. Neuroendocrine carcinoma is a tumor that begins in neuroendocrine cells and can spread, or metastasize, to other parts of the body. It starts in the hormone producing cells of the body’s neuroendocrine system. Neuroendocrine tumors can begin in many organs including, lungs, brain and ...Continue Reading

$5100

Global Oropharyngeal Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Oropharyngeal Cancer Therapeutics Market report
  • The global oropharyngeal cancer therapeutics market is expected to have significant growth since the pipeline for oropharyngeal cancer is growing rapidly. Also, there are no specific drugs available for the treatment of oropharyngeal cancer providing increased opportunities for the major key players. ...Continue Reading

$5100

Global Pancreatic Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Pancreatic Cancer Therapeutics Market report
  • The global pancreatic cancer therapeutics market holds numerous opportunities for the key players, as pancreatic cancer is a highly challenging disease among all types of cancer, which has no specific treatment available for it, as of now. Also, growing incidence of cancer and technological advancements are supporting the growth of the global pancreatic cancer therapeutics market growth. ...Continue Reading

$5100

Global Bile Duct Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Bile Duct Cancer Therapeutics Market report
  • The global bile duct cancer therapeutics market is expected to witness noticeable growth, in the near future, owing to increasing awareness about cancer and advancements in technologies for cancer treatment. Also, the increasing incidence of cancer is driving the bile duct cancer therapeutics market, globally. ...Continue Reading

$5100

Alzheimer’s Disease Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Alzheimers Disease Pipeline Analysis report
  • Alzheimer’s disease is a progressive brain disorder that gradually destroys thinking skills and memory, and ultimately the capability to carry out the basic tasks. Alzheimer’s disease is presently ranked as the third leading cause of death in the aging population, after heart disease and cancer. Alzheimer’s is the most common form of dementia among elder adults. Dementia is the loss of behavioral abilities and cognitive functioning which results in interference with a person’s daily life and activi ...Continue Reading

$4000

Estrogen Receptor-Positive Breast Cancer Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Estrogen Receptor Positive Breast Cancer Pipeline Analysis report
  • Estrogen Receptor-Positive (ER+) breast cancer is the most common type of breast cancer diagnosed and it refers to the cancer cells that have receptors on their surface to bind with estrogen. Breast cancer is said to be estrogen receptor-positive (ER+), if it contains estrogen that receives signals from estrogen to promote cell growth. Breast cancer is a syndrome that affects breast tissues and cells in the breast grow in an uncontrollable manner forming ...Continue Reading

$2500

Rhinovirus Infection Therapeutics – Clinical Pipeline Development Analysis

  • P&S Market Research Rhinovirus Infection Therapeutics Pipeline Analysis report
  • Rhinovirus is a small, non-enveloped, icosahedral virus having size of around 27 nm diameter. It contains one positive-strand RNA and belongs to Picornavirus family. Discovered in 1956, rhinovirus has over 100 antigenically distinct serotypes such as RhV A, RhV B groups, and RhV A2 and RhV C subclasses, based on their sequence similarity and cell entry receptors. Human rhinovirus is a positive-sense RNA virus of 7.2 kb single strand, having ...Continue Reading

$5100

Serine/Threonine-Protein Kinase Inhibitors Pipeline Analysis, 2017

  • P&S Market Research Serine Threonine Protein Kinase Inhibitors Pipeline Analysis report
  • Serine/threonine-protein kinases (EC 2.7.11.1) are enzyme or protein that has hydroxyl (OH) group in the side chain. Phosphorylation in serine or threonine residues may cause changes in the function of the target protein. Those drugs/ligands that inhibit phosphorylating activity of these kinases are called serine/threonine protein kinases inhibitors. Serine/threonine kinase receptors are a family of transmembrane receptors containing intracellular ...Continue Reading

$3250

Vasomotor Symptoms of Menopause Therapeutics Pipeline Analysis, 2017

  • P&S Market Research Vasomotor Symptoms of Menopause Therapeutics Pipeline Analysis report
  • Vasomotor symptoms occur when a woman reach the state of menopause and ovaries stop producing eggs, and there is a reduction in secretion of hormones such as estrogen and progesterone. It usually occurs naturally, most often between age of 45 years to 51 years. The women feel perimenopausal transition that generally occurs prior to cessation of menstruation. During perimenopausal transition, the menstruation cycle becomes ...Continue Reading

$3250

Janus Kinase (JAK) Inhibitors Pipeline Analysis, 2017

  • P&S Market Research Janus Kinase Inhibitors Pipeline Analysis report
  • Janus kinase (JAK) inhibitors block Janus kinase activator enzymes and interrupt signaling pathway. It plays an important role in host defense, oncology, autoimmunity and hematological cancers, which makes them an important target for therapeutics. Many signal transduction pathways are done by JAK activity for the normal signaling. The abnormal aberration in JAKs activity can lead to diseased state. For instance, over activation of JAK can lead to ...Continue Reading

$3250

Fungal Infections Pipeline Analysis, 2017

  • P&S Market Research Fungal Infections Pipeline Analysis report
  • Fungal Infection is a major cause of morbidity worldwide. Fungal Infections are caused by different fungi found in environment. Although, some fungi are not dangerous at all but few types of fungi are harmful to health. It involves the invasion of tissue such as skin and lung by specific type of fungi. According to Centers for Disease Control and Prevention (CDC), a public health institute in the U.S., approximately 1.5 million different species of fungi are present on ...Continue Reading

$3250

Hepcidin antagonist, Pipeline Analysis, 2017

  • P&S Market Research Hepcidin antagonist Pipeline Analysis report
  • Hepcidin is a small peptide which acts as iron regulatory hormone. The name ‘hepcidin’ is taken from the place of synthesis in hepatocytes (hep), whereas cidin denotes its antimicrobial activity. Liver is the key organ that secrete hepcidin and regulates iron hormone. Hepcidin was initially observed in human urine sample and in human blood ultrafiltrate as a small bactericidal peptide (defensin and cathelicidin) and now it is known as liver–expressed ...Continue Reading

$3250

Interstitial Cystitis (IC) Disease Pipeline Analysis

  • P&S Market Research Interstitial Cystitis Disease Pipeline Analysis report
  • Interstitial Cystitis (IC) is a painful bladder syndrome in which inflamed and irritated bladder cause recurring discomfort or pain. The symptoms of IC include an urgent or frequent need to urinate and pain during bladder filling. Women are more prone to develop this condition. Pain may be mild or so severe as to be debilitating and it can vary from day to day. IC is categorized into non-ulcerative and ulcerative. Non-ulcerative IC is the most common condition found in ...Continue Reading

$5100

Beta-Secretase (BACE) Inhibitors Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Beta Secretase Inhibitors Pipeline Analysis report
  • BACE is a cleaving enzyme of aspartyl protease with beta-secretase activity. It acts as a precursor of beta-amyloid (Aβ) protein. In Alzheimer’s disease, the Aβ protein fragments get accumulated in plaques in the brain. BACE initiates Aβ production by cleaving amyloid precursor protein (APP) to generate APPβ and C99, which is critical for the subsequent cleavage of C99 by gamma-secretase to release Aβ1-40 and Aβ1-42. Inhibition of BACE enzyme disrupts the ...Continue Reading

$1850

AKT/Protein Kinase B (PKB) Inhibitors Pipeline Analysis, 2017

  • P&S Market Research AKT Protein Kinase B Inhibitors Pipeline Analysis report
  • AKT, also known as Protein Kinase B (PKB), is overexpressed or activated in large number of human cancers, including breast, lung, gastric, ovary and pancreas. AKT inhibitor inhibits the activated form of AKT that leads to normal functioning of AKT kinases. AKT has three isoforms; AKT1, AKT2 and AKT3, which play an important role in regulation of diverse cellular functions such as metabolism, motility, cell survival, cell-cycle progression and transcription. ...Continue Reading

$3250

Global BET Inhibitors Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research BET Inhibitors Pipeline Analysis report
  • Bromodomain and extra-terminal (BET) inhibitors are small molecule inhibitors including bromodomain 2 (BRD2), bromodomain 3 (BRD3), bromodomain 4 (BRD4) and bromodomain testis (BRDT), which have anti-proliferating properties. These targets of inhibitors are supposed to bind with myc gene, which is a most desired target for cancer therapeutics. BET inhibitors are first-in-class targeted therapies that directly target bromodomain proteins to deliver a new ...Continue Reading

$2500

Global Idiopathic Pulmonary Fibrosis (IPF) Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Idiopathic Pulmonary Fibrosis Therapeutics Market report
  • Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs becomes stiff and dense over time. The scar tissue formation is known as fibrosis. As the fibrosis progresses and tissue become darker, lungs can't properly move oxygen into the bloodstream, which result in oxygen deficiency in brain and other organs. ...Continue Reading

$2500

Global T-Cell Immunotherapy Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research T Cell Immunotherapy Pipeline Analysis report
  • T-cell immunotherapy mainly consists of T-cell receptor (TCR), Tumor-infiltrating lymphocytes (TILs) and Chimeric antigen receptors (CAR) T-cell therapy. TCR is a complex integral membrane protein that activates T-cells in response to an antigen. ...Continue Reading

$4000

Global Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PD-L1) Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 – Industry Insights by Drug (Opdivo, Keytruda, Tecentriq, Durvalumab, Avelumab), by Mechanism of Action (PD-1 Inhibitor, PD-L1 Inhibitor)

  • P&S Market Research PD1 and PDL1 Inhibitors Market report
  • Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) inhibitors are the therapeutic candidates or drugs, popularly known as checkpoint inhibitors, used most commonly for the treatment of cancer and other malignancies. Programmed death 1 (PD-1) is found on the surface of cancer cells and it is used by tumor cells to evade the immune system. PD-1 inhibitors  ...Continue Reading

$6500

Global Protein A Resin Market Size, Share, Development, Growth and Demand Forecast to 2025

  • P&S Market Research Protein A Resin Market report
  • The global protein A resin market is expected to witness considerable growth during the forecast period due to the increasing research and development activities and increasing prevalence of chronic diseases. High traction for monoclonal antibodies in biopharmaceutical industry is supporting the growth of the global market. The increasing demand for monoclonal antibodies has fueled the need for high capacity commercial scale purification of monoclonal antibodies. Protein A resins are designed for the simple and rapid puri ...Continue Reading

$5100

Global Antibody Drug Conjugates (ADCs) Therapeutics Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research ADCs Therapeutics Market report
  • The global antibody drug conjugates (ADCs) therapeutics market is expected to witness significant growth due to current unmet medical need of some chronic diseases such as cancer and immunological diseases, increasing prevalence of such diseases, advancement in technologies and high demand for safe and effective medication. The regulatory bodies are supporting the ADCs market by providing designations and funding for speeding up the drug ...Continue Reading

$6500

Global Ocular Pain Treatment Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Ocular Pain Treatment Market report
  • The global ocular pain treatment market is expected to witness considerable growth due to increasing awareness about the eye disorders, technological advancement in ocular therapeutic and diagnostic test, and increasing number of lifestyle related ocular diseases. In addition, increasing geriatric population and increasing disposable income are further supporting the growth of the global ocular pain market. ...Continue Reading

$6500

Global Personalized Medicine Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Personalized Medicine Market report
  • The global personalized medicine market is expected to witness significant growth due rapid advancement in diagnostic techniques, population heterogeneity across the globe, increasing awareness about the benefits of genetic makeup based drugs, and improving quality of disease diagnosis. The key vendors in the global personalized medicine market are focusing on oncology, infectious disease and cardiovascular targeted treatment and diagnostics. ...Continue Reading

$6500

Global Chronic Pain Treatment Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Chronic Pain Treatment Market report
  • The global chronic pain treatment market is expected to witness considerable growth due to current unmet medical need of chronic pain, technological advancement in pain therapeutic and diagnostic test, and increasing number of chronic diseases such as cancer, arthritis, and diabetes mellitus. In addition, increasing geriatric population and increasing disposable income are supporting the growth of the global chronic pain market. The pharmaceutical ...Continue Reading

$6500

Global Endometrial Cancer Treatment Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research Endometrial Cancer Treatment Market report
  • The global endometrial cancer treatment market is expected to witness growth due to unmet need of treatment, technological advancement in cancer therapeutics and diagnostic test, rising prevalence of cancer, and sedentary lifestyle of women. In addition, increasing awareness about the uterine ...Continue Reading

$6500

Global Immune Checkpoint Inhibitors Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Immune Checkpoint Inhibitors Market report
  • The global immune checkpoint inhibitors market is expected to witness significant growth as these are proven to be more effective therapy in shrinking tumor in higher proportion of patients, as compared to other immunotherapies. Immune checkpoint inhibitors are applicable to a wider range of tumor types such as advanced or metastatic non-small cell lung cancer, renal cancer and melanoma. These inhibitors lower the rate of severe toxicities ...Continue Reading

$6500

Global Human Microbiome Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Human Microbiome Market report
  • The global human microbiome market is expected to witness significant growth due to increasing awareness towards healthy lifestyle, increasing demand for safe and effective medication, high number of patients with gastrointestinal diseases, inflammatory bowel diseases, obesity and cancer. The regulatory bodies are supporting the growth of market by providing designations and grants for speeding up the drug development process. Orphan drug designation and breakthrough therapy designation was given to RBX2660, a Rebiotix In ...Continue Reading

$6500

Global Graft Versus Host Disease (GVHD) Treatment Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research GVHD Treatment Market report
  • The global graft versus host disease (GVHD) treatment market is expected to witness considerable growth due to increasing number of hematopoietic stem cell transplantations (HSCTs), advancement in technologies, and increasing collaboration among the pharmaceutical companies. The regulatory bodies are supporting the graft versus host disease market by providing designations and grants for speeding up the drug development process. ...Continue Reading

$6500

Global Mammalian Target of Rapamycin (mTOR) Inhibitors Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research mTOR Inhibitors Market report
  • The global mammalian target of rapamycin (mTOR) inhibitors market is witnessing considerable growth due to their application in several therapeutic areas such as cancer, renal dysfunction and eye disorders. The regulatory bodies are providing funding and designation to the drug candidates for advancement of their products. Moreover, the increasing awareness related to the effective use of mTOR inhibitors, in combination with chemotherapy and its implications  ...Continue Reading

$6500

Global Natural Killer (NK) Cell Therapeutics Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research NK Cell Therapeutics Market report
  • The global natural killer (NK) cell therapeutics market is expected to witness considerable growth due to increasing awareness regarding immunotherapy, advancement in technologies, high demand for safe and effective medication, reduction of side effects, high prevalence of chronic diseases such as cancer and cardiovascular diseases, and increasing incidences of infectious diseases. The regulatory bodies are supporting the growth of the global market ...Continue Reading

$6500

Global Osteoporosis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulators, Rank Ligand Inhibitor, Calcitonin and Others)

  • P&S Market Research Osteoporosis Drugs Market report
  • The global osteoporosis drugs market was worth $8,835.4 million in 2015 and it is expected to grow at a CAGR of 3.8% during 2016-2022. Among the various drug classes, the rank ligand inhibitors segment is expected to witness the fastest growth, a CAGR of 4.3% during the forecast period. ...Continue Reading

$5100

Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Type (Dry AMD, and Wet AMD), by Drug (Lucentis, Eylea, Visudyne, Avastin and Others)

  • P&S Market Research Age Related Macular Degeneration Market report
  • The global age-related macular degeneration market accounted for revenue of $5,335.7 million in 2015, and it is expected to grow at a CAGR of 7.6% during 2016 - 2022. Among the various types, the wet AMD segment is expected to witness the faster growth during the forecast period. The global age-related macular degeneration market is growing at a significant rate, due to growing geriatric population, and increasing prevalence of age-related macular  ...Continue Reading

$4000

Global Muscle Relaxant Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Facial Aesthetic Relaxant Drug (Botox, Dysport, and Others), By Skeletal Muscle Relaxant Drug (Baclofen, Methocarbamol, Carisoprodol, Metaxalone, Tizanidine, and Others), and by Neuromuscular Blocking Agent (Non-depolarizing Agents, and Depolarizing Agents)

  • P&S Market Research Muscle Relaxant Drugs Market report
  • The global market of muscle relaxants is growing due to increase in geriatric population, increasing prevalence of skin diseases and harmful effects of ultra violet radiation. Old age is associated with the loss of fibrous tissue, and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered,  ...Continue Reading

$4500

Global Pain Management Drugs Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Pain Management Drugs Market report
  • The growing geriatric population and increasing demand of innovative and advanced pain relaxing medications around the world are the predominant growth drivers for the global pain management drugs market. Additionally, the increasing number of hospitalization cases; unmet requirements for neuropathic pain management drugs; innovative and advanced applications of  ...Continue Reading

$5100

Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Hepatitis A, Hepatitis B, Hepatitis C, and Others), by Hepatitis B Drugs (Baraclude, Viread, Tyzeka, Hepsera, and Others), and By Hepatitis C Drugs (Sovaldi, OLYSIO, Harvoni, Pegasys, PegIntron, Victrelis, and Others)

  • P&S Market Research Hepatitis Drugs Market report
  • The global market of hepatitis drugs is up surging with a significant rate, due to increasing incidences of hepatitis, and increasing support from government organizations. Hepatitis is one of the leading causes of death around the world. According to the Hepatitis B Foundation, every year around 1 million deaths are recorded due to hepatitis B and its complications around the  ...Continue Reading

$3500

Global Dermatology Drug Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Dermatology Drug Market report
  • The increasing prevalence of skin diseases and growing aging population around the world are the predominant growth drivers for the global dermatology drug market. Acne, psoriasis, and dermatitis are some common skin diseases. Acne is the most common dermatological condition, which is caused by clogging of hair follicles by sebum, dirt, and dead skin cells. Acne affects  ...Continue Reading

$5100

Global Biopharmaceuticals Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Monoclonal Antibodies, Recombinant Proteins, Interferon, Colony-Stimulating Factor, Erythropoietin, Recombinant Human Insulin, Vaccines, Growth Hormones, Purified Proteins and others) and by Application (Oncology, Inflammatory and Infectious Diseases, Metabolic Disorders, Neurological Disorders, Cardiovascular Diseases and Others)

  • P&S Market Research Biopharmaceuticals Market report
  • The global biopharmaceuticals market accounted for $ 160,440.4 million in 2014, and it is expected to grow with a CAGR of 9.6% during 2015-2020. The monoclonal antibodies market segment dominated the global biopharmaceuticals market in 2014 with about 25.8% share; whereas, among application segment, the oncology segment accounted for the highest share of 27% in the  ...Continue Reading

$5100

Global Anti-Obesity Drugs Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Anti Obesity Drugs Market report
  • The global anti-obesity drugs market is growing significantly, due to high prevalence of obesity and rich pipeline for anti-obesity drugs. The presence of large patient pool and massive unexplored market in the emerging economies, such as India and China, are creating ample opportunities for the growth of the global anti-obesity drugs market. The advanced research and development ...Continue Reading

$5100

Global Autoimmune Treatment Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Autoimmune Treatment Market report
  • The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent  ...Continue Reading

$5100

Global Contraceptives Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Contraceptives Market report
  • The global contraceptives market is growing significantly due to increasing incidences of unwanted pregnancies, increasing prevalence of sexually transmitted diseases and advances in contraception techniques. In addition, government and non-government organizations are funding and supporting programs to encourage contraception. Large unexplored contraceptives  ...Continue Reading

$5100

Global Influenza Vaccine Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Influenza Vaccine Market report
  • The global influenza vaccine market is growing significantly due increasing awareness about the pandemic influenza viruses and increasing government involvement for vaccination against influenza viruses.Massive unexplored influenza vaccine marketin the emerging economiesare creating ample opportunities for the global influenza vaccine marketto grow at a significant  ...Continue Reading

$5100

Global Nuclear Medicine (Radiopharmaceuticals) Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Nuclear Medicine Market report
  • The global nuclear medicine/radiopharmaceuticals market is growing significantly due to increasing prevalence of cancer and cardiovascular diseases, and advances in nuclear medicine imaging procedures. High demand of nuclear medicines in emerging economies and potential radiopharmaceuticals in the pipeline create ample opportunities for the nuclear  ...Continue Reading

$5100

Global Active Pharmaceutical Ingredients Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Active Pharmaceutical Ingredients Market report
  • The global active pharmaceutical ingredient market is growing significantly due to patent expiry of biologic drugs in the industry. Patent expiry of blockbuster drugs has boosted the demand for low cost substitutes, which further increases the demand for active pharmaceutical ingredients in the industry. Moreover, increasing investment into biosimilars is expected to support the  ...Continue Reading

$5100

Global Diabetic Nephropathy Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Diabetic Nephropathy Market report
  • The increase in research and development funds for drug discovery followed by growing awareness of kidney-related disorders, and diabetes are the major factors driving the expansion of the global diabetic nephropathy market. Globally, many programs are organized by the American Diabetes Association to prevent diabetes, create awareness among vulnerable populations, and  ...Continue Reading

$5100

Global Uveitis Treatment Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Uveitis Treatment Market report
  • Globally, North America is the largest, while Asia-Pacific is the fastest growing uveitis treatment market. The uveitis treatment market is witnessing significant growth, due to increasing prevalence of uveitis and related complications. The global uveitis treatment market currently has many technologically innovative products in the pipeline, which are expected to improve efficiency  ...Continue Reading

$5100

Global Restless Legs Syndrome Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Restless Legs Syndrome Market report
  • Restless legs syndrome increases at night when the patient is at rest. RLS are common in both, male and female; however the disease has its highest impact on woman who are elderly or in some cases woman with the age 35 to 50 years. Some of the most common symptoms of the restless legs syndrome are continue itching and pain in the legs, and unusual sleep pattern. The restless legs syndrome ...Continue Reading

$5100

Global Pompe Disease Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Pompe Disease Market report
  • Pompe disease is a type of lysergic acid diethylamide (LSD). LSD refers to a group of diseases arising from the increase of specific substrates and is inherited autosomal recessive disorders. Lysergic acid diethylamide is progressive and having uneven age of onset and clinical symptoms. Pompe disease is a hereditary and repeatedly incurable disorder caused by lack of acid  ...Continue Reading

$5100

Global Gastrointestinal Over the Counter (OTC) Drugs Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Gastrointestinal OTC Drugs Market report
  • Gastrointestinal diseases involve the gastrointestinal tract including stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver and pancreas. Over the counter (OTC) drugs are medications that are available without any prescription from the doctor. Over the counter drugs are chosen by regulatory agencies very carefully so as to ensure their efficacy and safety. ...Continue Reading

$5100

Global Opioid Induced Constipation Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Opioid Induced Constipation Market report
  • Opioids are directed to the patients suffering from the acute and chronic non-cancer pain. The opioids have numerous adverse intestinal effects, such as opioid-induced constipation. The opioids also affect the discharge of digestive enzymes that can sometime cause partial gastro paresis. Some of the most familiar symptoms of opioid-induced constipation includes, hard and dry  ...Continue Reading

$5100

Global Diabetic Retinopathy Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Diabetic Retinopathy Market report
  • Diabetic retinopathy refers to an eye disorder that damages or harms the blood vessels of the retina. Diabetic retinopathy can cause permanent blindness. Chronic diabetes is a major root of diabetic retinopathy. High glucose level in the blood can damage blood vessels in the retina. Diabetic retinopathy can also cause diabetic macular edema: a medical condition led to the leakage  ...Continue Reading

$5100

Global Cytomegalovirus Retinitis Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Cytomegalovirus Retinitis Market report
  • One of the major trends noticed in the cytomegalovirus retinitis market is usage of off-label drugs for the treatment of cytomegalovirus retinitis. Innovation of products focusing on better efficacy, growing demographics and growing economies in the developing countries, such as China and India, are some of the opportunities for global cytomegalovirus retinitis market.   ...Continue Reading

$5100

Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020

  • P&S Market Research Human Insulin Market report
  • Globally, modern human insulin has the largest market share and is also the fastest growing human insulin type. In addition, long acting human insulin has the largest market share in the modern human insulin market, and premixed human insulin is the fastest growing modern human insulin in the market. Long acting human insulin is prescribed by physicians for the treatment of  ...Continue Reading

$5100

Global Breast Cancer Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research  Breast Cancer Market report
  • Cancer is a disease characterized by uncontrolled growth of cell. There are about 100 different types of cancer and each is classified by the type of cell where it occurs and affects. Breast cancer is mostly prevalent in women, however, breast cancer in men is rare. It is frequently diagnosed in aged women and one of the leading causes of death among them. Some of the most  ...Continue Reading

$5100

Global Glaucoma Therapeutics Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Glaucoma Therapeutics Market report
  • Glaucoma is a disease of eye which is caused by excessive increase of fluid pressure within the eye. Glaucoma is caused due to mechanical compression or decreased blood flow in the optic nerve of the patient’s eye. If not treated properly, it may lead to mild loss of vision and even blindness. Treatment of glaucoma includes laser therapies, pharmaceutical drugs and surgical  ...Continue Reading

$5100

Global Asthma Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Asthma Market report
  • Asthma is a respiratory condition, where the airways become inflamed and narrow, which can cause a serious and incurable condition if left untreated. Breathlessness, wheezing and coughing are some of the symptoms of asthma and it can be controlled by avoiding triggers and with the help of drug therapy. Environmental triggers may vary from consumer to consumer but it can  ...Continue Reading

$5100

Global Choroidal Neovascularization (CNV) Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Choroidal Neovascularization Market report
  • Choroidal neovascular are the new blood vessels that grow just below the retina and interrupt the vision. Choroid, which is responsible for oxygen and nutrients supply to the eye, is the area between the retina and the sclera, where the blood vessels grow and cause choroidal neovascularization (CNV). Choroidal neovascularization break the barrier between retina and choroid  ...Continue Reading

$5100

Global Infectious Disease Treatment Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Infectious Disease Treatment report
  • Infectious diseases are medical conditions or disorders caused by microorganisms such as bacteria, fungi, viruses and other parasites. Several organisms are present in and on human bodies. Some organisms are normally harmless and even helpful. However, under certain circumstances, some organisms cause diseases. Infectious diseases spread from one person to another.  ...Continue Reading

$5100

Global Human Growth Hormone Market Size, Share, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Human Growth Hormone Market report
  • The global human growth hormone market is witnessing growth due to the presence of large pool of patients and technological advancements. The increasing compliance for human growth hormone drugs and massive unexplored market in the emerging economies, such as India and China are creating opportunities for the growth of the global human growth hormone market. The  ...Continue Reading

$5100

Let us know your requirements

Contact Us

  • U.S. Center : 347 5th Ave. #1402- 210 New York City, NY 10016 United States
  • Asian Address : B-28, Sector 1, Noida, U.P. - 201301 India.

Secure Online Payments

  • Payment